Insertion-deletion rate is a qualitative aspect of the tumor mutation burden associated with the clinical outcomes of gastric cancer patients treated with nivolumab. - Kim HD; Ryu MH; Park YS; Lee SY; Moon M; Kang YK (Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2022)